MAPS sent a letter today to NIDA Director Nora Volkow, Ph.D., responding to a November 18, 2003 letter from Dr. Volkow to Rick Doblin. This exchange of letters was part of a package of material that MAPS …
Editorial published in Movement Disorders by Stephen Kish, Ph.D., “What is the Evidence that Ecstasy (MDMA) Can Cause Parkinson’s Disease?” This strong editorial examines the evidence …
An article by Kelly Morris, entitled Concern over research reawakens ecstasy neurotoxicity debate is published in the journal Lancet: Neurology Vol 2, November 2003
Could MDMA help people with Parkinson’s disease ? A recently published study in marmosets suggests that MDMA can reduce side effects of some medicatios used in the treatment of PD.
Amazing Retraction! Dr. George Ricaurte retracted his paper published in Science on Sept. 27, 2002. He originally claimed that MDMA caused severe dopaminergic neurotoxicity in primates injected with a …
MAPS donated $15,046.25 to McLean Hospital, affiliated with Harvard Medical School. The donation is to enable Dr. John Halpern to develop a protocol for the use of MDMA-assisted psychotherapy in the treatment …
Letters in Science. An exchange of letters about MDMA dopaminergic neurotoxicity between the MAPS MDMA/PTSD team and the NIDA-funded research team of Ricaurte et al. appeared in the journal Science, June …
A Journal of the American Medical Association (JAMA) letter reports on the DanceSafe/MAPS pill testing program (the letter says people paid for their own testing but that was a mistake. MAPS paid for most …
A discussion about “Raves, Ecstasy and Youth” was held at the Shadow Convention 2000 in Los Angeles. A celebrity panel of MDMA researchers, experts and psychonauts was assembled by the Lindesmith …
